Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/09/036799
CTRI/2021/09/036799
Completed
Phase 3

Outcome of early short course corticosteroid therapy in Severe Community Acquired Pneumonia-A Randomized Controlled Trial.

one0 sites132 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
one
Enrollment
132
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 31, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
one

Eligibility Criteria

Inclusion Criteria

  • •All cases severe pneumonia will be diagnosed by following criteria:
  • •i) 2 months to 59 months: WHO criteria for severe pneumonia will be used.
  • •ii) 5 to 15 years: Child need to have tachypnea RR \>20/min, fever \>38 C, SPo2 \<94% and radiological changes in CXR to include as severe pneumonia in our study.

Exclusion Criteria

  • •1\.Prior treatment with corticosteroids in past 3 months
  • •2\.Immunological deficiencies state
  • •3\.Prexisting liver, kidney or cardiac disease
  • •4\.Nosocomial pneumonia
  • •5\.Brochiolitis, bronchial asthma, empyema thoracics, persistent or recurrent pneumonia
  • •6\.Hemodynamically instability
  • •7\.Severe acute malnutrition.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Rapid corticosteroid tapering in acute eosinophilic pneumoniaDiseases of th respiratory system
KCT0001352Armed Forces Capital Hospital59
Recruiting
Phase 2
Evaluation of the corticosteroids therapy without biliary stenting in patients with obstructive jaundice due to autoimmune pancreatitisType 1 autoimmune pancreatitis (AIP)
JPRN-UMIN000034194Bilio-Pancreatic Stenting study group100
Completed
Not Applicable
Corticosteroid in brucellosisBrucellosis.Brucellosis, unspecified
IRCT201106296922N1Zanjan University of Medical Sciences47
Active, not recruiting
Phase 1
Community-Acquired Pneumonia : Evaluation of COrticosteroiDs (CAPE COD)
EUCTR2015-001239-19-FRCHRU de TOURS1,200
Recruiting
Not Applicable
Efficacy and safety of corticosteroid monotherapy versus combination therapy of corticosteroid and tacrolimus for patients with anti-aminoacyl-tRNA synthetase antibody-positive polymyositis/dermatomyositis-associated interstitial lung disease: a prospective randomized multicenter clinical trialanti-aminoacyl-tRNA synthetase antibody-positive polymyositis/dermatomyositis/clinically amyopathic dermatomyositis-associated interstitial lung disease
JPRN-UMIN000032022Hamamatsu University School of Medicine66